Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + pravastatin versus simvastatin in type 2 diabetes with mixed hyperlipidemia
2006-006557-28Phase 3Completed
- Sponsor
- SMB Laboratoires
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate, pravastatin, simvastatin and ezetimibe in combined dyslipidaemia (4 arms), sponsored by SMB Laboratoires. Primary endpoints: Primary efficacy endpoint and Safety assessment. Started Mar 2007; status: completed.
02
Drugs
fenofibratepravastatinsimvastatinezetimibe
03
Conditions
combined dyslipidaemia
Beyond the preview
Go deeper on 2006-006557-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006557-28.